190 related articles for article (PubMed ID: 15655550)
1. Survivin, Survivin-2B, and Survivin-deItaEx3 expression in medulloblastoma: biologic markers of tumour morphology and clinical outcome.
Fangusaro JR; Jiang Y; Holloway MP; Caldas H; Singh V; Boué DR; Hayes J; Altura RA
Br J Cancer; 2005 Jan; 92(2):359-65. PubMed ID: 15655550
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of survivin splice isoforms in medulloblastomas.
Li XN; Shu Q; Su JM; Adesina AM; Wong KK; Perlaky L; Antalffy BA; Blaney SM; Lau CC
Neuropathol Appl Neurobiol; 2007 Feb; 33(1):67-76. PubMed ID: 17239009
[TBL] [Abstract][Full Text] [Related]
3. Survivin expression in medulloblastoma: a possible marker for survival.
Abdel-Aziz A; Mohamed MA; Akl FM; Taha AN
Pathol Oncol Res; 2013 Jul; 19(3):413-9. PubMed ID: 23242569
[TBL] [Abstract][Full Text] [Related]
4. Survivin is a negative prognostic marker in medulloblastoma.
Pizem J; Cört A; Zadravec-Zaletel L; Popovic M
Neuropathol Appl Neurobiol; 2005 Aug; 31(4):422-8. PubMed ID: 16008826
[TBL] [Abstract][Full Text] [Related]
5. Lack of prognostic significance of survivin in pediatric medulloblastoma.
Faccion RS; Ferreira RM; Grabois MF; Fonseca TC; de Oliveira JA; Maia RC
Pathol Oncol Res; 2011 Dec; 17(4):899-908. PubMed ID: 21681603
[TBL] [Abstract][Full Text] [Related]
6. Survivin expression in childhood medulloblastomas: a possible diagnostic and prognostic marker.
Bodey B; Bodey V; Siegel SE; Kaiser HE
In Vivo; 2004; 18(6):713-8. PubMed ID: 15646811
[TBL] [Abstract][Full Text] [Related]
7. The clinical significance of splice variants and subcellular localisation of survivin in non-small cell lung cancers.
Nakano J; Huang C; Liu D; Masuya D; Yokomise H; Ueno M; Haba R; Sumitomo S
Br J Cancer; 2008 Mar; 98(6):1109-17. PubMed ID: 18283319
[TBL] [Abstract][Full Text] [Related]
8. Overexpressed TP73 induces apoptosis in medulloblastoma.
Castellino RC; De Bortoli M; Lin LL; Skapura DG; Rajan JA; Adesina AM; Perlaky L; Irwin MS; Kim JY
BMC Cancer; 2007 Jul; 7():127. PubMed ID: 17626635
[TBL] [Abstract][Full Text] [Related]
9. Are overexpressed alternative survivin transcripts in human bladder cancer suitable targets for siRNA-mediated in vitro inhibition?
Wuttig D; Kunze D; Fuessel S; Toma M; Stade J; Kotzsch M; Kappler M; Taubert H; Schwenzer B; Baretton G; Hakenberg OW; Meye A; Wirth MP
Int J Oncol; 2007 Jun; 30(6):1317-24. PubMed ID: 17487351
[TBL] [Abstract][Full Text] [Related]
10. Histopathological prognostic factors in medulloblastoma: high expression of survivin is related to unfavourable outcome.
Haberler C; Slavc I; Czech T; Gelpi E; Heinzl H; Budka H; Urban C; Scarpatetti M; Ebetsberger-Dachs G; Schindler C; Jones N; Klein-Franke A; Maier H; Jauk B; Kiefer A; Hainfellner JA
Eur J Cancer; 2006 Nov; 42(17):2996-3003. PubMed ID: 16996732
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance and different properties of survivin splicing variants in gastric cancer.
Meng H; Lu C; Mabuchi H; Tanigawa N
Cancer Lett; 2004 Dec; 216(2):147-55. PubMed ID: 15533590
[TBL] [Abstract][Full Text] [Related]
12. Survivin splice variants regulate the balance between proliferation and cell death.
Caldas H; Jiang Y; Holloway MP; Fangusaro J; Mahotka C; Conway EM; Altura RA
Oncogene; 2005 Mar; 24(12):1994-2007. PubMed ID: 15688031
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patients.
Taubert H; Kappler M; Bache M; Bartel F; Köhler T; Lautenschläger C; Blümke K; Würl P; Schmidt H; Meye A; Hauptmann S
Oncogene; 2005 Aug; 24(33):5258-61. PubMed ID: 15856009
[TBL] [Abstract][Full Text] [Related]
14. Transthyretin expression in medulloblastomas and medulloblastoma cell lines.
Albrecht S; Bayer TA; Kraus JA; Pietsch T
Neuropathol Appl Neurobiol; 1995 Oct; 21(5):399-409. PubMed ID: 8632835
[TBL] [Abstract][Full Text] [Related]
15. A novel role of cyclinD1 and p16 in clinical pathology and prognosis of childhood medulloblastoma.
Zhao X; Song T; He Z; Tang L; Zhu Y
Med Oncol; 2010 Sep; 27(3):985-91. PubMed ID: 19806481
[TBL] [Abstract][Full Text] [Related]
16. Distinct expression of Survivin splice variants in breast carcinomas.
Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S
Int J Oncol; 2005 Oct; 27(4):1151-7. PubMed ID: 16142334
[TBL] [Abstract][Full Text] [Related]
17. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas.
Suga K; Yamamoto T; Yamada Y; Miyatake S; Nakagawa T; Tanigawa N
Oncol Rep; 2005 May; 13(5):891-7. PubMed ID: 15809755
[TBL] [Abstract][Full Text] [Related]
18. Role of survivin and its splice variants in tumorigenesis.
Li F
Br J Cancer; 2005 Jan; 92(2):212-6. PubMed ID: 15611788
[TBL] [Abstract][Full Text] [Related]
19. Replication stress, DNA damage signalling, and cytomegalovirus infection in human medulloblastomas.
Bartek J; Fornara O; Merchut-Maya JM; Maya-Mendoza A; Rahbar A; Stragliotto G; Broholm H; Svensson M; Sehested A; Söderberg Naucler C; Bartek J; Bartkova J
Mol Oncol; 2017 Aug; 11(8):945-964. PubMed ID: 28383788
[TBL] [Abstract][Full Text] [Related]
20. Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer.
Ryan B; O'Donovan N; Browne B; O'Shea C; Crown J; Hill AD; McDermott E; O'Higgins N; Duffy MJ
Br J Cancer; 2005 Jan; 92(1):120-4. PubMed ID: 15611790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
